NCT02802111View on ClinicalTrials.gov

Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Oxygen Consumption
Interventions
DRUG

Albuterol

Patient receives albuterol 5 mg aerosolized. Oxygen consumption and vital signs are measured for 1 hour after intervention.

DRUG

Levalbuterol

Patient receives levalbuterol 2.5 mg aerosolized. Oxygen consumption and vital signs are measured for 1 hour after intervention

All Listed Sponsors
lead

Children's Hospital Los Angeles

OTHER

NCT02802111 - Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults | Biotech Hunter | Biotech Hunter